Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Quality Lowdown: ICH Q9, FDA QMM, THC Impurities And Recertified MAPPs

26 Jan 2023

• By Bowman Cox

The Quality Lowdown

Related Content

Manufacturing Regulatory Updates In Brief: Elemental Impurities, Class 3 Biowaivers, FDA Salt Policy

28 Dec 2017

The Quality Lowdown: Coronavirus Prompts EU To Extend Comment Deadline For Annex 1

11 May 2020

US FDA Makes Case For Quality Management Maturity Ratings

11 Apr 2022

ICH Q9 Revision Delayed By Three Months Due To COVID; Focus Spans Risk Assessments, Shortages

13 Oct 2021

US CBD Supplement Market Anxious For Lawful Use Proposal, And FDA Offers Cannabis Drug Research Guidance

23 Jul 2020

Additional Topics

Compliance Manufacturing Quality Risk Management Cannabidiol CBD

More from Compliance

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.